Kenji Osafune

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 17

Top Topics

Induced Pluripotent Stem Cells

Top Venues

Scientific reports

Journal of diabetes investigation

American journal of physiology. Renal physiology

Artificial organs

This page only lists publications with an associated author ORCID identifier.

Publications

Ryuichiro Hirayama, Kosuke Toyohara, Kei Watanabe, Takeya Otsuki, Toshikazu Araoka, Shin-Ichi Mae, Tomoko Horinouchi, Tomohiko Yamamura, Keisuke Okita, Akitsu Hotta, Kazumoto Iijima, Kandai Nozu, Kenji Osafune
iPSC-derived type IV collagen α5-expressing kidney organoids model Alport syndrome. Communications biology 6 (1) (2023)
Hiraku Tsujimoto, Naoko Katagiri, Yoshihiro Ijiri, Ben Sasaki, Yoshifumi Kobayashi, Akira Mima, Makoto Ryosaka, Kenichiro Furuyama, Yoshiya Kawaguchi, Kenji Osafune
In vitro methods to ensure absence of residual undifferentiated human induced pluripotent stem cells intermingled in induced nephron progenitor cells. PloS one 17 (11) (2022)
Kazuyoshi Yamamoto, Masahiro Okabe, Keiko Tanaka, Takashi Yokoo, Ira H Pastan, Toshikazu Araoka, Kenji Osafune, Tomohiro Udagawa, Masahiro Koizumi, Taiji Matsusaka
Podocytes are lost from glomeruli before completing apoptosis. American journal of physiology. Renal physiology 323 (5) (2022)
Tatsuya Shimizu, Kunihiro Yamagata, Kenji Osafune
Kidney organoids: Research in developmental biology and emerging applications. Development, growth & differentiation 63 (2) (2021)
Kenji Osafune
Regenerative treatments for kidney diseases: The closest and fastest strategies to solving related medical and economic problems. Artificial organs 45 (5) (2021)
Hiraku Tsujimoto, Kenji Osafune
Current status and future directions of clinical applications using iPS cells-focus on Japan. The FEBS journal (2021)
Kenji Osafune
iPSC technology-based regenerative medicine for kidney diseases. Clinical and experimental nephrology 25 (6) (2021)
Takayuki Hamabata, Katsutsugu Umeda, Kagehiro Kouzuki, Takayuki Tanaka, Tomoo Daifu, Seishiro Nodomi, Satoshi Saida, Itaru Kato, Shiro Baba, Hidefumi Hiramatsu, Mitsujiro Osawa, Akira Niwa, Megumu K Saito, Yasuhiko Kamikubo, Souichi Adachi, Yoshiko Hashii, Akira Shimada, Hiroyoshi Watanabe, Kenji Osafune, Keisuke Okita, Tatsutoshi Nakahata, Kenichiro Watanabe, Junko Takita, Toshio Heike
Author Correction: Pluripotent stem cell model of Shwachman-Diamond syndrome reveals apoptotic predisposition of hemoangiogenic progenitors. Scientific reports 11 (1) (2021)
Daisuke Yamazaki, Yoshio Konishi, Takashi Morikawa, Hideki Kobara, Tsutomu Masaki, Hirofumhi Hitomi, Kenji Osafune, Daisuke Nakano, Wararat Kittikulsuth, Akira Nishiyama
Failure to confirm a sodium-glucose cotransporter 2 inhibitor-induced hematopoietic effect in non-diabetic rats with renal anemia. Journal of diabetes investigation 11 (4) (2020)
Takayuki Hamabata, Katsutsugu Umeda, Kagehiro Kouzuki, Takayuki Tanaka, Tomoo Daifu, Seishiro Nodomi, Satoshi Saida, Itaru Kato, Shiro Baba, Hidefumi Hiramatsu, Mitsujiro Osawa, Akira Niwa, Megumu K Saito, Yasuhiko Kamikubo, Souichi Adachi, Yoshiko Hashii, Akira Shimada, Hiroyoshi Watanabe, Kenji Osafune, Keisuke Okita, Tatsutoshi Nakahata, Kenichiro Watanabe, Junko Takita, Toshio Heike
Pluripotent stem cell model of Shwachman-Diamond syndrome reveals apoptotic predisposition of hemoangiogenic progenitors. Scientific reports 10 (1) (2020)
Azusa Hoshina, Tatsuya Kawamoto, Shin-Ichi Sueta, Shin-Ichi Mae, Toshikazu Araoka, Hiromi Tanaka, Yasunori Sato, Yukiko Yamagishi, Kenji Osafune
Author Correction: Development of new method to enrich human iPSC-derived renal progenitors using cell surface markers. Scientific reports 9 (1) (2019)
Hirofumi Hitomi, Tomoko Kasahara, Naoko Katagiri, Azusa Hoshina, Shin-Ichi Mae, Maki Kotaka, Takafumi Toyohara, Asadur Rahman, Daisuke Nakano, Akira Niwa, Megumu K Saito, Tatsutoshi Nakahata, Akira Nishiyama, Kenji Osafune
Human pluripotent stem cell-derived erythropoietin-producing cells ameliorate renal anemia in mice. Science translational medicine 9 (409) (2018)
Azusa Hoshina, Tatsuya Kawamoto, Shin-Ichi Sueta, Shin-Ichi Mae, Toshikazu Araoka, Hiromi Tanaka, Yasunori Sato, Yukiko Yamagishi, Kenji Osafune
Development of new method to enrich human iPSC-derived renal progenitors using cell surface markers. Scientific reports 8 (1) (2018)
Yoshiya Hosakawa, Taro Toyoda, Kenji Fukui, Megu Yamaguchi Baden, Michinori Funato, Yasushi Kondo, Tomomi Sudo, Hiromi Iwahashi, Marina Kishida, Chihiro Okada, Akira Watanabe, Isao Asaka, Kenji Osafune, Akihisa Imagawa, Iichiro Shimomura
Insulin-producing cells derived from 'induced pluripotent stem cells' of patients with fulminant type 1 diabetes: Vulnerability to cytokine insults and increased expression of apoptosis-related genes. Journal of diabetes investigation (2017)
Maki Kotaka, Taro Toyoda, Katsutaro Yasuda, Yuko Kitano, Chihiro Okada, Akira Ohta, Akira Watanabe, Motonari Uesugi, Kenji Osafune
Adrenergic receptor agonists induce the differentiation of pluripotent stem cell-derived hepatoblasts into hepatocyte-like cells. Scientific reports 7 (1) (2017)
Yasushi Kondo, Taro Toyoda, Nobuya Inagaki, Kenji Osafune
iPSC technology-based regenerative therapy for diabetes. Journal of diabetes investigation 9 (2) (2017)
Timothy J Kieffer, Knut Woltjen, Kenji Osafune, Daisuke Yabe, Nobuya Inagaki
Beta-cell replacement strategies for diabetes. Journal of diabetes investigation (2017)